Showing results (1441-1450 of 3,185) with videos related to

Sort By:
Pageof 319
Translational Oncology|May 5, 2024
CircVDAC3 sequesters microRNA-592 and elevates EIF4E3 expression to inhibit the progression of gastric cancerTian-Ning Yang, Ruo-Wen Xiao, Fei Su, et al.
Translational Oncology|May 3, 2024
TCF19 promotes cell proliferation and tumor formation in lung cancer by activating the Raf/MEK/ERK signaling pathwayYahui Tian, Shaowei Xin, Zitong Wan, et al.
Translational Oncology|November 8, 2023
Fam198b as a novel biomarker for gastric cancer and a potential therapeutic target to prevent tumor cell proliferation dysregulationBangquan Chen, Maladho Tanta Diallo, Yue Ma, et al.
Translational Oncology|October 12, 2023
The relationship between dietary inflammatory potential and cancer outcomes among cancer survivors: A systematic review and meta-analysis of cohort studiesEric Han, Eunkyung Lee, Brian Sukhu, et al.
Translational Oncology|October 16, 2023
CYB5R1 is a potential biomarker that correlates with stemness and drug resistance in gastric cancerQin Zhang, Yufan Ma, Yongfeng Yan, et al.
Translational Oncology|October 15, 2023
SERPINH1 enhances the malignancy of osteosarcoma via PI3K-Akt signaling pathwayKezhou Xia, Xinghan Huang, Yingchun Zhao, et al.
Translational Oncology|October 8, 2023
Circulating cytokine dynamics as potential biomarker of response to anti-PD-1 immunotherapy in BRAFwt MM patientsKatarina Mirjačić Martinović, Ana Vuletić, Nevena Tišma Miletić, et al.
Translational Oncology|October 1, 2024
FERMT1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by activating EGFR/AKT/β-catenin and EGFR/ERK pathwaysWubin Guo, Mengnan Liu, Wei Luo, et al.
Translational Oncology|September 24, 2024
MicroRNA-376a-3p sensitizes CPT-11-resistant colorectal cancer by enhancing apoptosis and reversing the epithelial-to-mesenchymal transition (EMT) through the IGF1R/PI3K/AKT pathwayChikondi Jassi, Wei-Wen Kuo, Yu-Chun Chang, et al.
Translational Oncology|September 13, 2024
Characterization of DNA damage repair pathway utilization in high-grade serous ovarian cancers yields rational therapeutic approachesErika Nakatsuka, Lijun Tan, Brianna Cunneen, et al.
Pageof 319